title: Transdermal patches: the emerging mode of drug delivery system in psychiatry.
abstract: Adherence to prescribed psychiatric and nonpsychiatric medication is a serious issue in people with mental illness that can contribute to poor health outcomes. Some of the factors influencing adherence include side effects of medication and the ease of use. With mental healthcare provision increasingly focusing on a community model of health delivery, there seems to be a renewed interest in addressing complex dilemmas of safety and adherence to treatment. The use of alternative methods of safely delivering medication in innovative ways may resolve some of these difficulties. There has been little discussion about the wider use of transdermal patches in the field of psychiatry in published literature. This article describes the findings from the literature on key principles underlying transdermal delivery strategies, the scope of clinical use in psychiatric illness and explores its challenges and advantages.
authors: SouthWest London and St George's Mental Health Trust, Tooting, London, UK.
authors: Miriam
authors: M
authors: Isaac
authors: Carl
authors: C
authors: Holvey
keywords: Adherence; patches; psychotropics; safety; transdermal
references: J Pharm Pharmacol. 2008 Jun;60(6):689-92
references: 18498703
references: J Atten Disord. 2006 Feb;9(3):476-85
references: 16481664
references: Eur J Pharm Biopharm. 2001 Sep;52(2):103-12
references: 11522474
references: Pharmazie. 2001 Mar;56(3):231-4
references: 11265590
references: BMJ Case Rep. 2009;2009:
references: 22114625
references: Neurology. 2000 Jan 11;54(1):233-5
references: 10636157
references: Int J Pharm. 2001 Aug 14;224(1-2):1-18
references: 11512545
references: J Affect Disord. 2008 Jan;105(1-3):15-23
references: 17568687
references: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146
references: 18253970
references: Psychopharmacology (Berl). 2008 Jun;198(2):149-58
references: 18327673
references: J Atten Disord. 2011 Jan;15(1):28-35
references: 20439487
references: Addiction. 2007 Oct;102(10):1648-56
references: 17854341
references: Curr Drug Deliv. 2005 Jan;2(1):23-33
references: 16305405
references: Curr Med Chem. 2000 Jun;7(6):593-608
references: 10702628
references: Br J Gen Pract. 1990 Mar;40(332):114-6
references: 2112014
references: Drugs Aging. 2002;19(8):561-70
references: 12207550
references: J Clin Psychiatry. 2008 Jan;69(1):149-59
references: 18312050
references: Prev Med. 1997 Mar-Apr;26(2):264-70
references: 9085397
references: Clin Pharmacol Ther. 1985 Oct;38(4):450-6
references: 4042528
references: Drugs Today (Barc). 2010 Jul;46(7):483-505
references: 20683503
references: J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):308-12
references: 10945804
references: Curr Med Res Opin. 2007 Dec;23(12):3199-204
references: 18001519
references: Neurology. 2007 Jul 24;69(4 Suppl 1):S23-8
references: 17646620
references: J Psychopharmacol. 2004 Jun;18(2):277-80
references: 15260918
references: Expert Opin Biol Ther. 2002 Oct;2(7):723-33
references: 12387671
references: AAPS PharmSciTech. 2005 Sep 30;6(2):E144-9
references: 16353971
references: Neurology. 2007 Jul 24;69(4 Suppl 1):S10-3
references: 17646618
references: Pediatrics. 2007 Nov;120(5):1100-6
references: 17974748
references: J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700-708
references: 18434918
references: J Pharmacol Exp Ther. 1998 May;285(2):457-63
references: 9580583